Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | February 2005

Carotid Imaging: A Cardiologist's Perspective

By Rajesh M. Dave, MD

evt | Article | August 2007

Orbital Atherectomy for Infrapopliteal Occlusions

A treatment option for critical limb ischemia.

By Rajesh M. Dave, MD, FACC, FSCAI

evt | Article | January 2006

Renal Artery Stenting With Embolic Protection

Embolic protection during renal stenting may be beneficial, but new device designs are necessary.

By Rajesh M. Dave, MD

Sponsored by Cardinal Health (formerly AccessClosure)

evt | Article | February 2015

The MYNX ACE® Vascular Closure Device

Early experience demonstrates reliability and patient comfort.

By Rajesh M. Dave, MD, FACC, FSCAI

Advertisement

Advertisement

Sponsored by Ra Medical Systems, Inc.

evt | Article | August 2019

Case Report: Successfully Tackling the Complex Clinical Challenge of Isolated Popliteal Artery Disease With Excimer Laser Photoablation and PTA

By Rajesh M. Davé,, MD, FACC, FSCAI

evt | News | January 12, 2010

CELLO Study Published for Spectranetics' Turbo-Booster

January 13, 2010—Spectranetics Corporation (Colorado Springs, CO) announced that Rajesh M. Dave, MD, et al have published results of the CELLO (Clirpath Excimer Laser System to Enlarge Lumen Openings) registry in the Journal of Endovascular Therapy (2009;16:665–675). CELLO evaluated the effectiveness of excimer laser ablation with the company's Turbo-Booster for patients with peripheral artery disease (PAD).

evt | News | January 12, 2010

Published CELLO Study Demonstrates Effectiveness of Spectranetics’ Turbo-Booster Excimer Laser Ablation System

January 13, 2010—Spectranetics Corporation (Colorado Springs, CO) announced that Rajesh M. Dave, MD, et al have published results of the CELLO (Clirpath Excimer Laser System to Enlarge Lumen Openings) registry in the Journal of Endovascular Therapy (2009;16:665–675). CELLO evaluated the effectiveness of excimer laser ablation with the company's Turbo-Booster for patients with peripheral arterial disease (PAD).

evt | Article | January 2006

Renal Artery Therapy

By Barry T. Katzen, MD Chief Medical Editor

evt | Article | August 2007

Options For Treating CLI

By John R. Laird, Jr, MD

evt | Article | February 2005

Evolving Standards, Emerging Debates

By John R. Laird, Jr, MD

evt | Article | January 2007

Renal Intervention Roundtable

Experts discuss the current issues surrounding renal artery therapy.

By Rajesh Dave, MD; Matthew Edwards, MD; and Thomas A. Sos, MD

evt | Article | January 2007

Renal Therapy and Fishing: Let's Catch More King Salmon

By Takao Ohki, MD, PhD, Chief Medical Editor

evt | Article | October 2011

SFA: A Closer Look

By John R. Laird, MD

evt | Article | August 2016

Five Essential Components to Treating Peripheral Artery Disease and Critical Limb Ischemia

By Nicholas J. Petruzzi, MD; Lori Richwine, DO; Rajesh Patel, MD; and Michael Schmidling, MD

evt | Article | January 2016

Establishing a Community Hospital Interventional Oncology Program: Essential Equipment and Services

The first in a three-part series on the most important components of starting a successful practice.

By Nicholas J. Petruzzi, MD; Rajesh Patel, MD; Mitchell Brezel, MD; and Michael Schmidling, MD

evt | Article | January 2016

From Trauma to Treatment: Optimizing Vascular Trauma Patient Management

A look at improving the care of traumatic vascular injuries in a new era of vascular surgery.

By Vahram Ornekian, MD, MS; Jack Sava, MD; and Rajesh K. Malik, MD, RPVI

Sponsored by Silk Road Medical

evt | Article | January 2022 Supplement

TCAR Limitations: Separating Fact From Fiction

With Rasesh M. Shah, MD, FACS, and Susan M. Shafii, MD, MHSA, FACS, FSVS

Sponsored by Silk Road Medical

evt | Article | August 2020 Supplement

Transitioning to the TCAR-First Strategy for Carotid Revascularization

By Rasesh M. Shah, MD, FACS, and H. Edward Garrett Jr, MD, FACS

Sponsored by Silk Road Medical

evt | Article | August 2020 Supplement

The Evolution of TCAR Into First-Line Therapy for Carotid Revascularization

By Rasesh M. Shah, MD, FACS

evt | News | September 7, 2022

Silk Road Medical Begins ROADSTER 3 Postapproval Study of TCAR System in Patients at Standard Surgical Risk

September 7, 2022—Silk Road Medical, Inc. announced enrollment of the first patient in the ROADSTER 3 postapproval study of the company’s system for transcarotid artery revascularization (TCAR) of patients at standard surgical risk with carotid artery disease in real-world treatment.


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button